6313-55-9 Usage
General Description
2-amino-6-chloropyridine-4-carboxylic acid is a chemical compound with the molecular formula C6H5ClN2O2. It is a heterocyclic compound containing a pyridine ring with a chloro substituent at the 6 position and a carboxylic acid group at the 4 position. 2-amino-6-chloropyridine-4-carboxylic acid is commonly used in chemical and pharmaceutical synthesis, particularly in the production of pharmaceutical drugs and organic compounds. It has potential applications in the development of new drugs and biologically active molecules due to its structural properties and reactivity. Additionally, 2-amino-6-chloropyridine-4-carboxylic acid can also be used as a building block in the synthesis of novel materials and organic compounds for various industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 6313-55-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,1 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6313-55:
(6*6)+(5*3)+(4*1)+(3*3)+(2*5)+(1*5)=79
79 % 10 = 9
So 6313-55-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H5ClN2O2/c7-4-1-3(6(10)11)2-5(8)9-4/h1-2H,(H2,8,9)(H,10,11)
6313-55-9Relevant articles and documents
SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
-
, (2015/09/23)
Inhibitors of HBV replication of Formula (A) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein Ra to Rd, and R5 to R6 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES
-
Page/Page column 81-82, (2011/10/05)
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular Itk activity.